Chinese Journal of Mycology 2013, Vol. 8 Issue (5): 316-320.
Received:2013-07-02
Online:2013-10-28
Published:2013-10-28
CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: http://cjmycology.smmu.edu.cn:81/Jweb_zgzj/EN/
http://cjmycology.smmu.edu.cn:81/Jweb_zgzj/EN/Y2013/V8/I5/316
| [1] Jose Sifuentes-Osornio,Dora E. Epidemiology of Invasive Fungal Infections in Latin[J].Curr Fungal Infect Rep,2012,6(1): 3-34. [2] Ma CF, Li FQ, Shi LN,et al.Surveillance study of species distribution, antifungal susceptibility and mortality of nosocomial candidemia in a tertiary care hospital in China[J].BMC Infect Dis,2013,13: 337. [3] Yap HY,Kwok KM,Gomersall CD,et al. Epidemiology and outcome of Candida bloodstream infection in an intensive care unit in Hong Kong[J].Hong Kong Med J,2009,15(4):255-261. [4] Pemán J, Zaragoza R. Current diagnostic approaches to invasive candidiasis in critical care settings[J]. Mycoses,2010,53(5):424-433. [5] Falagas ME, Apostolou KE, Pappas VD. Attributable mortality of candidemia: a systematic review of matched cohort and case-control studies[J]. Clin Microbiol Infect Dis,2006,25(7): 419-425. [6] Marchetti O,Lamoth F,Mikulska M,et al.ECIL recommendations for the use of biological markers for the diagnosis of invasive fungal diseases in leukemic patients and hematopoietic SCT recipients[J]Bone Marrow Transplant,2012,47(6):846-854. [7] Lamoth F,Cruciani M,Mengoli C, et al.Third European Conference on Infections in Leukemia (ECIL-3) (2012) β-Glucan antigenemia assay for the diagnosis of invasive fungal infections in patients with hematological malignancies: a systematic review and meta-analysis of cohort studies from the Third European Conference on Infections in Leukemia (ECIL-3).[J]Clin Infect Dis,2012, 54(5):633-643. [8] 郭云武. 血浆1,3-β-D-葡聚糖诊断侵袭性真菌感染的meta分析[J]. 中国卫生检验杂志,2013,23(2):483-486. [9] Karageorgopoulos DE, Vouloumanou EK, Ntziora F,et al. β-D-glucan assay for the diagnosis of invasive fungal infections: a meta-analysis[J]. Clin Infect Dis,2011,52(6):750-770. [10] Onishi A, Sugiyama D, Kogata Y,et al. Diagnostic accuracy of serum 1,3-β-D-glucan for pneumocystis jiroveci pneumonia, invasive candidiasis, and invasive aspergillosis: systematic review and meta-analysis[J]. Clin Microbiol,2012,50(1):7-15. [11] Lamoth F, Cruciani M, Mengoli C etal.β-Glucan antigenemia assay for the diagnosis of invasive fungal infections in patients with hematological malignancies: a systematic review and meta-analysis of cohort studies from the Third European Conference onInfections in Leukemia (ECIL-3)[J].Clin Infect Dis,2012,54(5):633-643. [12] Usami M, Ohata A, Horiuchi T etal.Positive (1-->3)-beta-D-glucan in blood components and release of (1-->3)-beta-D-glucan from depth-type membrane filters for blood processing[J]. Transfusion,2002,42(9):1189-1195. [13] Mohr JF, Sims C, Paetznick V,et al. Prospective survey of (1,3)-β-d-glucan and its relationship to invasive candidiasis in the surgical intensive care unit setting[J]. Clin. Microbiol,2011,49(1):58-61. [14] Posteraro B, De Pascale G, Tumbarello M,et al. Early diagnosis of candidemia in intensive care unit patients with sepsis: a prospective comparison of (1,3)-β-d-glucan assay,Candida score, and colonization index[J]. Crit Care,2011,15(5):249. [15] Acosta J, Catalan M, del Palacio-Pérez-Medel A,et al. Prospective study in critically ill non-neutropenic patients: diagnostic potential of (1,3)-β-d-glucan assay and circulating galactomannan for the diagnosis of invasive fungal disease[J].Clin.Microbiol.Infect. Dis,2012,31(5):721-731. [16] Cuenca-Estrella M,Verweij PE,Arendrup MC,et al.ESCMID guideline for the diagnosis and management of Candida diseases 2012: diagnostic procedures[J].Clin Microbiol Infect,2012, 18 (Suppl 7):9-18. [17] Sims CR, Jaijakul S, Mohr J,et al. Correlation of clinical outcomes with β-glucan levels in patients with invasive candidiasis[J]. Clin Microbiol.2012,50(6):2104-2106. [18] Yang GH, Sheng ZY. The value of assay of (1, 3)-β-D-glucan in bronchoalveolar lavage fluid for detection of invasive pulmonary fungal infection in critically ill patients in intensive care unit[J].Zhongguo Wei Zhong Bing Ji Jiu Yi Xue,2012,24(2):90-95. [19] De Pauw B, Walsh TJ, Donnelly JP,et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group[J]. Clin Infect Dis,2008,46(12):1813-1821. [20] Sendid B, Poirot JL, Tabouret M,et al.Combined detection of mannanaemia and antimannan antibodies as a strategy for the diagnosis of systemic infection caused by pathogenic Candida species[J].Med Microbiol,2002,51(5):433-442. [21] Prella M, Bille J, Pugnale M,et al. Early diagnosis of invasive candidiasis with mannan antigenemia and antimannan antibodies[J]. Diagn Microbiol Infect Dis,2005,51(2):95-101. [22] Pemán J, Zaragoza R. Combined Use of Nonculturebased Lab Techniques in the Diagnosis and Management of Critically ill Patients with Invasive Fungal Infections[J].Expert Rev Anti Infect Ther, 2012,10(11):1321-1330. [23] Sun HY, Chiu YS, Tang JL,et al. The usefulness of the Platelia Candida antigen in a patient with acute lymphocytic leukemia and chronic disseminated candidiasis[J].Med Mycol,2006,44(7):647-650. [24] Caggiano G, Puntillo F, Coretti C,et al.Candida colonization index in patients admitted to an ICU[J].Int J Mol Sci, 2011,12(10):7038-7047. [25] Verduyn Lunel FM, Donnelly JP,et al.Circulating Candida-specific anti-mannan antibodies precede invasive candidiasis in patients undergoing myelo-ablative chemotherapy[J].Clin Microbiol Infect,2009,15(4):380-386. [26] Mikulska M, Calandra T, Sanguinetti M,et al.The use of mannan antigen and anti-mannan antibodies in the diagnosis of invasive candidiasis: recommendations from the Third European Conference on Infections in Leukemia[J].Crit Care,2010,14(6):222. [27] Laín A, Moragues MD, Ruiz JC,et al. Evaluation of a novel enzyme-linked immunosorbent assay to detect immunoglobulin G antibody to enolase for serodiagnosis of invasive candidiasis[J]. Clin. Vaccine Immunol,2007,14(3),318-319. [28] Pitarch A, Jiménez A,et al.Serological proteome analysis to identify systemic candidiasis patients in the intensive care unit: Analytical, diagnostic and prognostic validation of anti-Candida enolase antibodies on quantitative clinical platforms[J].Proteomics Clin Appl, 2008,2(4):596-618. [29] Pitarch A, Jiménez A, Nombela C,et al.Decoding serological response to Candida cell wall immunome into novel diagnostic, prognostic, and therapeutic candidates for systemic candidiasis by Proteomic and bioinformatic analyses[J]. Mol Cell Proteomics,2006,5(1):79-96. [30] Li Wq, Hu Xc, Zhang,et al.Immunisation with the glycolytic enzyme enolase confers effective protection against Candida albicans infection in mice[J].Vaccine,2011,29(33):5526-5533. [31] Held J, Kohlberger I,et al.Comparison of (1->3)-β-D-glucan, mannan/anti-mannan antibodies, and Cand-Tec Candida antigen as serum biomarkers for candidemia[J].Clin Microbiol,2013,51(4):1158-1164. [32] Takazono T, Izumikawa K,et al.Evaluation of the Cica Fungi Test Candida, a novel serum Candida mannan antigen kit, and its comparison with Cand-Tec in candidemia patients[J].Jpn J Infect Dis,2011,64(2):116-120. [33] Misaki H, Iwasaki H, Ueda T.A comparison of the specificity and sensitivity of two Candida antigen assay systems for the diagnosis of deep candidiasis in patients with hematologic diseases[J].Med Sci Monit,2003,9(2):MT1-7. [34] Bär W, Hecker H.Diagnosis of systemic Candida infections in patients of the intensive care unit. Significance of serum antigens and antibodies[J].Mycoses,2002,45(1-2):22-28. [35] Ibàñez-Nolla J, Torres-Rodríguez JM,et al.The utility of serology in diagnosing candidosis in non-neutropenic critically ill patients[J].Mycoses,2001,44(1-2):47-53. [36] Zaragoza R, Pemán J, Quindós G,et al. Clinical significance of the detection of Candida albicans germ tube-specific antibodies in critically ill patients[J]. Clin Microbiol Infect,2009;15(6):592-595. [37] Quindós G, Moragues MD, Pontón J. Is there a role for antibody testing in the diagnosis of invasive candidiasis[J]? Rev Iberoam Micol,2004,21(1):10-14. [38] Maertens J, Buvé K, Theunissen K,et al. Galactomannan serves as a surrogate endpoint for outcome of pulmonary invasive aspergillosis in neutropenic hematology patients[J]. Cancer,2009,115(2),355-362. [39] Moragues MD, Ortiz N, Iruretagoyena JR,et al. Evaluation of a new commercial test (Candida albicans IFA IgG) for the serodiagnosis of invasive candidiasis[J]. Enferm Infecc Microbiol Clin 2004,22(2): 83-88. [40] Zaragoza R, Pemán J, Ramirez P,et al. Clinical and management utility of Candida germ tube antibody detection in critically ill patients.Preliminary data 46 th Interscience Conference on Antimicrobial Agents and Chemotherapy: San Francisco, CA, 2006(Abstract M-1618). [41] Zaragoza R, Pemán J, Quindós G,et al. Kinetic patterns of Candida albicans germ tube antibody in critically ill patients: influence on mortality[J].Clin.Vaccine Immunol,2009,16(10),1527-1528. [42] Pemán J, Zaragoza R, Quindós G,et al. Clinical factors associated with a Candida albicans germ tube antibody positive test in intensive care unit patients[J]. BMC Infect. Dis,2011,11(1):60. [43] Damiens S, Poissy J, François N,et al.Mannose-binding lectin levels and variation during invasive candidiasis[J].Clin Immunol,2012,32(6):1317-1323. [44] Gropp K, Schild L, Schindler S, et al.The yeast Candida albicans evades human complement attack by secretion of aspartic proteases[J].Mol Immunol, 2009,47(2-3):465-475. [45] Quanping S, Yanyan H, Yicun W, et al.The use of hybrid phage displaying antigen epitope and recombinant protein in the diagnosis of systemic Candida albicans infection in rabbits and cancer patients[J].Diagn Microbiol Infect Dis,2010,68(4):382-389. [46] Laín A, Moragues MD, Ruiz JC,et al. Diagnosis of invasive candidiasis by enzyme-linked immunosorbent assay using the N-terminal fragment of Candida albicans hyphal wall protein 1[J].Clin Vaccine Immunol,2007,14(3),318-319. [47] Clancy CJ, Nguyen ML, Cheng S,et al. Immunoglobulin G responses to a panel of Candida albicans antigens as accurate and early markers for the presence of systemic candidiasis[J].Clin microbiol,2008,46(5),1647-1654. [48] Philip A, Odabasi Z, Matiuzzi G,et al.Syscan3, a kit for detection of anti-Candida antibodies for diagnosis of invasive candidiasis[J].Clin Microbiol,2005,43(9):4834-4835. |
| [1] | WANG Chong, ZHAN Ping, LIU Wei-da. Advances in the application of Matrix-assisted laser desorption ionization time-of-flight mass spectrometry for identification of clinically pathogenic fungi [J]. Chinese Journal of Mycology, 2013, 8(6): 369-373. |
| [2] | FAN Xin, WANG He, SU Xiao-xiang, XIAO Meng, MA Xue-fei, MA Chao-yue, LIU Xu-guang, MA Ran, WU Yue, CHEN Yan-zhao, XU Ying-chun. Evaluation of Rapid ID Yeast Plus and API20C AUX systems in identification of yeast species,using molecular identification as ‘gold-standard’ [J]. Chinese Journal of Mycology, 2013, 8(5): 274-280. |
| [3] | DOU Hong-tao, XIAO Meng, FAN Xin, YANG Qi-wen, WANG Yao, WANG He, LIU Juan, XIE Xiu-li, XU Ying-chun. Evaluation of BD PhoenixTM in identification of the yeast by using clinical yeasts [J]. Chinese Journal of Mycology, 2013, 8(5): 281-284. |
| [4] | JIN Ying, YANG Shuang-feng, WANG Jun-fang, LIU Jin, CUI Yun-tao, ZHOU Xin, ZHAO Hua-bing. Rapid clinical yeast identification by Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry [J]. Chinese Journal of Mycology, 2012, (5): 269-272. |
| [5] | . [J]. Chinese Journal of Mycology, 2012, (5): 309-311. |
| [6] | . [J]. Chinese Journal of Mycology, 2012, (5): 312-315. |
| [7] | LIU Chun-yu, WANG Hong, REN Ai-min, DU Kun, HU Lan, LI Shi-rong, WEN Yan, ZHANG Shu-wen. Diagnostic value of (1-3) -β-D-glucan for invasive fungal infection:a clinical research [J]. Chinese Journal of Mycology, 2012, (4): 207-210. |
| [8] | HUANG Ling-li, ZHANG Wen-hong, LI Li, ZHANG Qiang-qiang. The survey of oropharyngeal and nasal fungal isolation rate in HIV-infected patients [J]. Chinese Journal of Mycology, 2012, (4): 211-213. |
| [9] | CHENG Juan-juan, PAN Min, HAN Zhi-jun, GE Xiao-li. Clinical significance of increased serum IL-27 in children with mycosis intestinalis [J]. Chinese Journal of Mycology, 2012, 7(1): 24-26. |
| [10] | GAO Lu-juan, YU Jin, LI Ruo-yu. Update of real-time PCR in the diagnosis of invasive Aspergillosis [J]. Chinese Journal of Mycology, 2012, 7(1): 59-64. |
| [11] | YANG Hui-qing, MEI Ya-ning. Clinical value of(1,3)-β-D-glucan in plasma on the diagnosis of deep fungal infection [J]. Chinese Journal of Mycology, 2011, 6(3): 136-140. |
| [12] | . [J]. Chinese Journal of Mycology, 2011, 6(2): 122-125. |
| [13] | . [J]. Chinese Journal of Mycology, 2011, 6(1): 57-60. |
| [14] | . [J]. Chinese Journal of Mycology, 2010, 5(6): 376-380. |
| [15] | . [J]. Chinese Journal of Mycology, 2010, 5(6): 381-384. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
